Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3078% above fair value
$0.45+0.03 (+7.88%)
Close on Nov 13, 2026Market cap $91.28MP/E –Yield –
Lucid Diagnostics gross margin
Gross margin is gross profit as a percentage of revenue.
Lucid Diagnostics's gross margin for the twelve months ending Sep 30, 2026 was -16.5%. For fiscal 2025 it was -41.7%, against -63.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -41.7% | +21.6 |
| FY2024 | Dec 31, 2024 | -63.3% | −163.3 |
| FY2022 | Dec 31, 2022 | 100.0% | +0.0 |
| FY2021 | Dec 31, 2021 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -16.7% | +23.4 |
| Q2 FY2026 | Jun 30, 2026 | 2.0% | +36.4 |
| Q1 FY2026 | Mar 31, 2026 | -29.4% | +57.9 |
| Q4 FY2025 | Dec 31, 2025 | -23.7% | −123.7 |
| Q3 FY2025 | Sep 30, 2025 | -40.1% | −140.1 |
| Q2 FY2025 | Jun 30, 2025 | -34.4% | +60.8 |
| Q1 FY2025 | Mar 31, 2025 | -87.3% | −187.3 |
| Q4 FY2022 | Dec 31, 2022 | 100.0% | +0.0 |
| Q3 FY2022 | Sep 30, 2022 | 100.0% | – |
| Q1 FY2022 | Mar 31, 2022 | -95.2% | – |
| Q4 FY2021 | Dec 31, 2021 | 100.0% | – |
| Q3 FY2021 | Sep 30, 2021 | 100.0% | – |
See a number that looks wrong?